March 2024
21 Aug 2024
The global biochips market surpassed USD 11.28 billion in 2023 and is projected to be worth around USD 37.19 billion by 2033, poised to grow at a CAGR of 12.67% during the forecast period. The biochips market is in high demand due to their ability to perform rapid biological experiments effortlessly.
The Full Study is Readily Available | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/4805
A biochip is a microprocessor chip, using which more than a hundred biochemical reactions can occur instantly, such as decoding genes. They are designed to function in a biological environment, especially inside a living organism. It consists of millions of biosensors that act as microreactors to detect particular analytes, including enzymes, proteins, biological molecules, and antibodies.
The growth of the biochips market is driven by funding for life science research and development provided by both government and private sectors. The application of biochip is used in various fields, such as genomics, proteomics, drug discovery, and diagnostics.
Using biochips, approximately 80,000 genes in human DNA have been identified quickly. To date, over 8 million animals have been chipped. Biochips are tagged on farm and ranch animals with radio-frequency identification (RFID) and passive integrated transponders (PITs) to find lost animals and avoid expenses for housing, food, medical care, outplacing, and euthanasia.
Biochip Technology for Personalised Medicine
Biochip is a smart healthcare device that offers continuous monitoring of patients' symptoms. Personalized medicine is a rising practice of modifying medicine according to the individual’s genetic profile, considering prevention and treatment of diseases and diagnosis.
Advances in biochip and microarray technologies contribute to the development of personalized medicine. The use of biochips (e.g., GeneChip, CYP450, electrochemical biochips, protein biochips, microfluidic biochips, and nanotechnology-based biochips) plays an important role in molecular diagnostics, and their application in point-of-care diagnosis is expected to improve the development of personalized medicine.
However, some harmful side effects have also been noticed when biochips have been implanted. The presence of toxic substances and metals may cause an allergic reaction or any serious condition. Additionally, biochips can store personal identification data, which can lead to security and privacy concerns. Also, the biochip industry is highly expensive because of the complexity of designing and fabricating, the cost of raw materials and equipment required for manufacturing
Recent Development by Creoptix in the BioChips Market
| Company Name | Creoptix |
| Headquarters | Wädenswil, Switzerland |
| Development | In June 2022, Creoptix added two new wizards to their WAVE control software. Through this, Creoptix will develop biological drug discovery and diagnosis. The two wizards are ligand screening - a fast and effective way to screen and characterize antibodies. This works in a ligand block logic with each automated block of activity, such as ligand capture, sample injection, and surface regeneration. Second is the calibration-free concentration analysis (CFCA), which is a quick and easy calibration-free way to achieve active protein concentration. |
Recent Development by Affymetrix Inc. in the BioChips Market
| Company Name | Affymetrix Inc. |
| Headquarters | California, United States |
| Development | Thermo Fisher Scientific’s the parent organization of Affymetrix Inc., has announced the launch of a new plant. Thermo Fisher Scientific’s gene therapy manufacturing company already has branches in Massachusetts, Belgium, Cambridge, and Lexington. It is the fifth most popular company to manufacture viral vectors, vector stands of virus and it sells to drug companies. |
North America dominated the global biochips market in 2023. The region holds a strong lead on several multinational companies and start-ups of biochip developers. In this region, government support is involved in the R&D department through tax incentives; due to this factor, the region is anticipated to maintain its position in the market. Along with the existence of biotechnology companies, academic and research institutes are assumed to boost the further growth and advancement of the biochips market.
North America and Canada are also prone to chronic disease and cancer. The majority of the patients are prescribed personalized medicine. This has resulted in rising advancements in personalized medicine for adequate diagnosis.
Asia Pacific is expected to grow at the fastest CAGR in the biochips market during the forecast period, with a noticeable expansion in pharma and biotechnology industries in countries including China and India. The rise in healthcare costs and personalized medicine is increasing the adoption of biochips in countries like China, Japan, South Korea, and India. The growing use of biochip technology is influencing the expansion of a particular region.
Market Potential & Growth Opportunity
Combination microfluid (or lab-on-a-chip) technology with biochip has significant growth in the biochips market. It will make an advancement in various applications such as DNA analysis, molecular biological techniques, proteomics (the study of protein), and clinical pathology for disease diagnosis. Microfluidic devices are mostly manufactured using ultraviolet lithography, an extremely complex technique that uses thousands of components, is expensive, and requires specialized instruments and trained professionals.
A microfluidic device can be used to diagnose infectious diseases quickly at the initial stage. A wide range of epidemiological studies use this technology. Using the fabrication technology, the biochips are segmented into microarrays and microfluidics. They are classified as material glass, polymers, silicon, and others. Research and development in the microfluid department aim to develop personalized disease screening, monitoring, and drug response testing using saliva or blood samples.
| Report Attribute | Key Statistics |
| Market Revenue in 2024 | USD 12.71 Billion |
| Market Revenue by 2033 | USD 37.19 Billion |
| CAGR | 12.67% |
| Quantitative Units | Revenue in USD million/billion, Volume in units |
| Largest Market | North America |
| Base Year | 2023 |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Market Segmentation
By Type
By Fabrication Technology
By End-user
Buy this Research Report@ https://www.precedenceresearch.com/checkout/4805
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 650 460 3308
March 2024
March 2024
March 2024
July 2024